Professor of Medicine and Director,
University of Michigan Scleroderma Program,
Dr Dinesh Khanna, MD, MSc, is a Professor of Medicine and Director of the University of Michigan Scleroderma Program. Dr Khanna has published over 250 peer-reviewed articles and book chapters. Aside from his role as a Principal Investigator on National Institutes of Health and industry-sponsored clinical studies, Dr Khanna also serves as a reviewer for several professional journals, society committees and training programs, and grant applications. His current research focuses on developing, validating, and refining outcome measures in rheumatic diseases and designing controlled trials. He is leading the development of patient reported outcome measures in rheumatic diseases and developing composite response index for clinical trials in scleroderma; both projects are funded by the National Institutes of Health. He received the 2011 "Doctor of the Year" award from the Scleroderma Foundation and 2015 Henry Kunkel Young Investigator Award from the American College of Rheumatology.
Department of Medicine, Solna,
and Karolinska University Hospital,
Prof Ingrid Lundberg completed her medical education at Karolinska Institutet, Stockholm, Sweden in 1977. Her rheumatology residency was completed at Skövde hospital and Huddinge University Hospital, Stockholm. In parallel with clinical rheumatology service at Huddinge University Hospital, she completed her PhD with the title ”Clinical and immunological studies of patients with anti-RNP antibodies” at Karolinska Institutet in 1991. After her PhD she spent one year as a post doc at the neuromuscular laboratory, Mayo Clinic, Rochester under Dr Andrew Engel to learn more about muscle histopathology and new techniques to study molecular expression in muscle tissue. In 1998 she was appointed associate professor in rheumatology and since 2003 she is full professor in rheumatology at Karolinska Institutet combined with a position as senior consultant at Karolinska University hospital. Dr Lundberg spends 1/3 of her time in research, 1/3 with education and 1/3 with clinical work. Since 2012 she is chair of the Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet.
After her return from Mayo clinic in 1993 she was recruited to Karolinska University hospital, Stockholm where she established a myositis clinic with a dedicated multidisciplinary team. This clinic has formed the basis of a translational research project with the aim to achieve improved understanding of molecular mechanisms that lead to muscle weakness in patients with myositis. She has also established national, SweMyoNet, and international multidisciplinary collaborations on myositis, www.myonet.eu, important for this rare disorder. Through the international MyoNet she has been in the lead of the development of a web-based myositis register, www.euromyositis.eu that now has more than 3 500 patients from 23 centers worldwide enrolled. Dr. Lundberg has also been leading a multidisciplinary project to develop new classification criteria for myositis, EULAR-ACR classification criteria for myositis.
As an active ACR member, Dr Lundberg has presented at a Clinical review course and with scientific lectures at ACR meetings. She has served as Advisory Editor and Associate Editor of Arthritis & Rheumatology and served as ACR Abstract Category Co-Chair for Muscle Biology, Myositis and Myopathies. She joined the International Myositis Assessment and Clinical Studies (IMACS) from the start in year 2000 and has contributed at the annual meetings with update on international initiatives. She has served the Swedish Society for Rheumatology, the Scandinavian Society for Rheumatology and EULAR as chair of Standing Committee of Education and Training (ESCET) and as member of the executive committee.
Dr Lundberg is the recipient of several distinctions and awards including the Scandinavian Journal Prize in Rheumatology Research (2001), The Swedish Rheumatism Association memory of Professor Nanna Svartz (2002), Honorary lecture “Börje Olhagen Lecture” The Swedish Society for Medicine (2002), Medal from Karl University, Prague, Czech Republic (2008), The major Wyeth prize in Rheumatology (2008), Karolina Prize for Quality care work in myositis, Karolinska University Hospital (2009), Master Award, American College of Rheumatology (2015) and The Excellence in Investigative Mentoring award, American College of Rheumatology (2016).
Clinical Professor of Medicine,
Division of Rheumatology, Department of Medicine,
David Geffen School of Medicine at UCLA,
Dr. Fan practices rheumatology and clinical immunology in North Hollywood, California. He went to medical school in Canada at the University of Manitoba, internship and residency in internal medicine at L.A. County-USC Medical Center and fellowship in rheumatology at UCLA School of Medicine. He joined the Division of Rheumatology at the David Geffen School of Medicine at UCLA in 1976 and has served as Clinical Professor of Medicine since 1991. In 1981, together with colleagues at UCLA, Dr. Fan reported the first cases of the AIDS syndrome. He was previously Chief of Rheumatology at the West Los Angeles Veterans Administration Medical Center and has been visiting professor and lecturer in Finland, Japan, China, Hong Kong, Malaysia, Singapore, Philippines and Thailand. He has published in the New England Journal of Medicine, Annals of Internal Medicine, Arthritis & Rheumatism, Journal of Immunology and many other journals and has written chapters for standard textbooks of rheumatology. He is a consultant for Best Doctors of America and serves on the advisory board of the International Journal of Rheumatology. He was past chair of the Southern California Chapter of the Arthritis Foundation and past president of the Southern California Rheumatology Society. He is the recipient of awards and honors for teaching, patient care, voluntary services and patient advocacy; in April 2017 his fellow rheumatologists in California honored him with the California Rheumatology Alliance Life Time Achievement Award.
Duke-NUS Graduate Medical School, and
Department of Paediatrics, National University of Singapore;
Senior Consultant and Head,
Rheumatology and Immunology Service,
Department of Paediatric Subspecialties,
KK Women's and Children's Hospital,
A/Prof Arkachaisri is the Associate Professor of Paediatrics in the Department of Paediatrics, National University of Singapore and the Head and Senior Consultant in Rheumatology/Immunology Service, Department of Paediatric Subspecialties at KK Women’s and Children’s Hospital. He is also the Site Programme Director for the SingHealth Rheumatology Senior Residency Programme and the TTSH Rheumatology Senior Residency Program. He is the Faculty Coordinator at Duke – NUS GMS Pediatric Elective Clerkship, core faculty at ACGME Pediatric Residency Training Program, SingHealth and the member of the Paediatric Workgroup for Joint Examination with ABMS. A/Prof Arkachaisri holds the Visiting Instructorship for the Scleroderma Programme at the Children’s Hospital of Pittsburgh.
A/Prof Arkachaisri holds Memberships in several professional and scientific societies. He is the Executive Committee member, National Arthritis Foundation, Singapore, Fellow of the American College of Rheumatology and member of the Asia-Pacific League of Associations for Rheumatology (APLAR), Thai Rheumatism Association, Royal College of Paediatricians of Thailand, Paediatric Association of Thailand, Medical Council of Thailand and is the Ramathibodi Medical Alumni.
A/Prof Arkachaisri is the recipient of several awards and honours including Singapore Health Quality Service Award (Gold Category in 2016 and Silver Category in 2015), KKH Service from the Heart Award (2015), MOH Singapore, Commendation Prize for 9th Quality Improvement Conference (2012), Duke-NUS Faculty Appreciation Awards (Outstanding faculty for Development), SingHealth Residency: RiSE Award for Best Innovative Faculty and RiSE Award for Outstanding Mentor.
Senior Consultant Neurologist,
Department of Neurology,
National Neuroscience Institute,
Subang Jaya Medical Centre;
Visiting Rheumatologist, National University Malaysia Medical Centre,
Dr Heselynn Hussein [MBBCh (Cardiff, U.K), FRCP (London), FAMM (Malaysia)] is currently Consultant Rheumatologist at Subang Jaya Medical Centre in the state of Selangor, Malaysia and visiting rheumatologist at the National University Malaysia Medical Centre.
Dr Hussein graduated from the University of Wales College of Medicine, Cardiff, UK. She obtained her MRCP (London) in 1993 and her FRCP in 2007. Dr Hussein underwent specialty training in rheumatology at the National University Hospital Malaysia, and further trained in Birmingham, UK. She also obtained a postgraduate certificate in herbal medicine from Napier University in Edinburgh and trained in musculoskeletal ultrasound at Glasgow Royal Infirmary in Glasgow, Scotland.
Prior to her current appointments, Dr Hussein was Head of Department of Medicine and head of Rheumatology at Hospital Putrajaya. In addition, Dr Hussein has served as Trainer for the Rheumatology Fellowship Program, Malaysian Ministry of Health, Rheumatology credentialling board secretary, and Content Writer and Editorial Board Member for the Malaysian Telehealth Project Health-on-Line.
Dr Hussein has a special interest in rheumatoid arthritis and gout. She maintains active clinical research programmes and has published extensively on these topics. She has participated in many clinical trials and also embarked on collaborative research projects with other centres.
Dr Hussein is the Immediate Past President of the Malaysian Society of Rheumatology. She was President of the Malaysian SLE Association, Internal Auditor of the Arthritis Foundation of Malaysia, and Vice-President of the Klang Hospice Association.
Subang Jaya Medical Centre,
Dr Yeap Swan Sim [MBChB (Dundee), MD (Dundee), FRCP (Edinburgh), FRCP (London), CCST (UK), FAM (Malaysia)] is a Consultant Rheumatologist at Subang Jaya Medical Centre, Selangor, Malaysia. Her previous appointments include Associate Professor and Head of the Rheumatology Unit at the Department of Medicine, University of Malaya.
She is the current Vice-President of the Malaysian Osteoporosis Society and its Immediate Past President, a Past President of the Malaysian Society of Rheumatology, and was previously a Vice-President of the Asia-Pacific League of Associations for Rheumatology (APLAR).
She was the Co-Chairperson of the Working Group for the 2012 Clinical Guidance on the Management of Osteoporosis and its revision in 2015, served as an Expert Panel Committee Member of the Clinical Practice Guidelines (CPG) on the Management of Osteoarthritis of the Hip and Knee (2001-2002) and as Editor and Expert Panel Committee Member if the CPG on the Management of Gout (2003-2004, 2006-2008). In addition, she currently serves on the Editorial Board of the International Journal of Rheumatic Diseases. Her research interests focus on osteoporosis, rheumatoid arthritis and systemic lupus erythematosus.
Division of Rheumatology,
National University Hospital,
Professor of Rheumatology,
University of Liverpool,
Robert Moots is Professor of Rheumatology at the University of Liverpool, Director of the University of Liverpool Academic Rheumatology Unit and Consultant Rheumatologist at Aintree University Hospital. After qualifying in Medicine in London, UK, Dr Moots subsequently trained in immunology at the Institute for Molecular Medicine at the University of Oxford, where he earned his PhD. Dr Moots continued his research at Harvard Medical School. He returned to the UK in 1997 and in 2002 became the youngest full Professor of Rheumatology and Head of Department appointed in the UK.
Dr Moots’ research interests lie in clinical and basic science aspects of rheumatic diseases, from bench to bedside. He has published extensively, won the prestigious Michael Mason prize for rheumatology research, is active in international medical and scientific societies and committees and each year receives invitations to lecture on every continent. Dr Moots has extensive experience in drug development - working with the pharmaceutical industry internationally and with bodies such as the UK National Institute for Health and Clinical Excellence (NICE). He is Medical Advisor to major UK patient groups and in 2009 took over as Editor-in-Chief of Rheumatology. Clinical service remains an important part of his work and his unit has recently been designated UK National Centre for Behçet’s disease.
Department of Medicine,
Tuen Mun Hospital ,
Hong Kong SAR, China
Chi-Chiu Mok is currently the chief of the Division of Rheumatology, Department of Medicine, Tuen Mun Hospital, Hong Kong. He is a consultant physician and an honorary teaching professor of the Chinese University of Hong Kong. Dr. Mok is the chairman of the Research Committee of his hospital and is the convener of the rheumatology service development group within the Hospital Authority of Hong Kong. In addition, Dr. Mok serves as the program director of the Rheumatology / Immunology accreditation board of the Hong Kong College of Physicians.
An active researcher, Dr. Mok is the first author of more than 180 papers in a number of medical and Rheumatology journals including the Annals of the Rheumatic Diseases, Nature Review Rheumatology, Arthritis and Rheumatology, Rheumatology (Oxford), and Arthritis Care & Research. His research interests include systemic lupus erythematosus, particularly lupus nephritis, and glucocorticoid induced osteoporosis. Dr. Mok is also the principal investigator of more than 10 phase II/III global trials investigating the safety and efficacy of novel biological agents in various rheumatic diseases.
Dr. Mok is currently the senior associate editor of the International Journal of Rheumatic Diseases and an editorial member of the Journal of Rheumatology, Current Rheumatology Review, Open Orthopedic Journal and Immunology and Immunogenetic Insights. In addition, he is an ad-hoc reviewer of more than 60 medical and rheumatology journals.
Dr. Mok is a Past President of the Hong Kong Society of Rheumatology. He is the founder editor of the Hong Kong Bulletin on Rheumatic Diseases, the official publication of the Hong Kong Society of Rheumatology.
Professor of Medicine, Memorial,
Staff Rheumatologist,Eastern Health
Royal Brisbane and Women’s Hospital,
Dr Philip C Robinson currently works as the Consultant Rheumatologist at the Royal Brisbane and Women's Hospital. Previously he also serves as the Staff Specialist Rheumatology at Logan Hospital and as the Director of Clinical Training, Australian Rheumatology Association Queensland Branch. Dr Robinson consults for a number of pharmaceutical companies in relation to patient education, pharmacoeconomic applications, clinician education and meeting organization.
Dr Robinson trained in medicine at the University of Otago in New Zealand. He then completed specialty training in general and acute care medicine and rheumatology in Wellington and Dunedin, New Zealand. He then completed a PhD in genetics at the University of Queensland Diamantina Insititute.
Dr Robinson holds several professional memberships. He is the Associate Member of the Assessment of Spondyloarthritis Special Society (ASAS), Member of the Australian Rheumatology Association, International Fellow of the American College of Rheumatology and the Associate Member of the New Zealand Rheumatology Association. He is also the member of Rheumatology Specialty Training Committee, Royal Australasian College of Physicians, Scientific Advisory Board, Australian Rheumatology Association Research Trust, NZ Joint Executive and NZ Adult Medicine Education Committee, Royal Australasian College of Physicians.
Dr Robinson's primary research interest lies in the inflammatory crystal arthritis gout and the disease associations of serum urate including cardiometabolic disease and neurodegenerative disease. He also has an interest in spondyloarthritis (ankylosing spondylitis, axial spondyloarthritis and psoriatic arthritis), as well as classification criteria in rheumatic diseases and inflammatory eye disease.
Professor of Medicine,
University of Bologna,
Prof Claudio Borghi is Professor of Medicine at the University of Bologna. He received his medical degree at the University of Bologna and completed his clinical fellowship at the Department of Cardiology and then at the Department of Clinical Pharmacology of the University of Bologna. His research experience is mainly focused on the clinical epidemiology of CV risk factors and the pharmacological and therapeutic aspects of hypertension, coronary artery disease and congestive heart failure.
He is currently Chief of the Department of Medicine of the Policlinico S.Orsola-Malpighi-Bologna and Head of the Hypertension Unit and the ESH Excellence Center for hypertension. He is the immediate Past-President of the Italian Society of Hypertension and chairmen of the Foundation for Hypertension Research of the same Society. Prof Borghi is also the Head of the post-graduate medical school for Emergency Medicine. He is Delegate for the International relationships of the School of Medicine of University of Bologna. He is member of the Executive Council of the International Society of Hypertension and the European Society of Hypertension
Prof Borghi has lectured to primary care physicians and several specialists (cardiologists, internists, diabetologists, nephrologists) about hypertension, cardiovascular risk factors, lipid lowering drugs, clinical pharmacology of cardiovascular drugs, treatment of CV diseases. He has a broad experience in the organization and conduction of all phases clinical trial research and has served as principal Investigator of many large morbidity and mortality trials and epidemiological surveys in hypertension, hyperuricemia, coronary artery disease and atherosclerotic disease.
Prof Borghi is currently the National Coordinator for the ACCELERATE Study, FORWARD Study. He is also a member of the Working Group of Clinical Pharmacology and Therapeutic and member of the writing committee for the guidelines about the management of cardiovascular diseases during pregnancy of the European Society of Cardiology. Prof.Borghi has authored and co-authored over 390 peer-review scientific papers and many other scientific publications and scientific contributions in the field of hypertension, CHD and drug treatment of cardiovascular diseases.
Duke-National University of Singapore;
Head and Senior Consultant,
Department of Rheumatology and Immunology,
Singapore General Hospital, Singapore
Dr Low is the Senior Consultant and Head of the Department of Rheumatology and Immunology in Singapore General Hospital. She is the Assistant Professor at the Duke-National University of Singapore, Graduate Medical School and Clinical Senior Lecturer at the Yong Loo Lin School of Medicine. She is also a visiting consultant at the National Heart Centre (Combined Pulmonary Hypertension Clinic). She underwent her Rheumatology training in the United Kingdom and Singapore and continued her sub-specialisation at Mount Sinai Hospital, University of Toronto with a fellowship in systemic sclerosis. She subsequently obtained the Master of Clinical Investigation in clinical research at the National University of Singapore.
Dr Low’s clinical and research interest lies in systemic sclerosis and the overlap connective tissue diseases. She spearheaded the national systemic sclerosis database and leads collaborative research efforts for new therapies in systemic sclerosis. She is also a recipient of the Medicine Academic Clinical Program Nurturing Clinician Scientist award and the National Medical Research Council Transition Award. She has secured over $2 million in grant funding for her work in systemic sclerosis.
Dr Low is a Fellow of the Academy of Medicine Singapore (Rheumatology) and member of the Chapter of Rheumatologists, Singapore. She is a journal reviewer for several regional and international journals. She has also mentored several medical students and residents.
University Malaya Medical Centre,
Kuala Lumpur, Malaysia
Dr Sargunan Sockalingam is Head of the Rheumatology Unit at University Malaya Medical Centre (UMMC) and Associate Professor at the Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. He is also the current president of the Arthritis Foundation Malaysia.
After obtaining his MBBS from the Manipal Academy of Higher Education in Karnataka, India, Dr. Sargunan served as a medical officer at the Queen Elizabeth Hospital in Kota Kinabalu, Sabah, Malaysia. He went on to receive his specialty training in Internal Medicine at UMMC. He remained at UMMC to teach Internal Medicine and Rheumatology, before completing his fellowship at St George Hospital, University of New South Wales in Sydney, Australia. Since then, Dr. Sargunan has dedicated his career toward leading the Rheumatology unit of UMMC as the premier University clinical, research and rheumatology training center in Malaysia.
Besides intensive clinical work, Dr Sargunan’s main interest is in teaching and guiding aspiring medical professionals to reach their full potential as accomplished physicians through informative and engaging lectures. He is also active in corporate training and is currently working on developing digital healthcare platforms. Dr. Sargunan has published a number of articles in peer reviewed journals, namely Lupus and the International Journal of Rheumatic Diseases.
Senior Consultant and Director,
Research of Department of Rheumatology and Immunology,
Singapore General Hospital
A/Prof Katy Leung is a Clinical Scientist at Singapore general Hospital (SGH). She is also currently a Senior Consultant and Director of Research of department of Rheumatology and Immunology at SGH. Her interests in research include osteoarthritis, psoriatic arthritis and health related quality of life. She is currently working group member for Group in Research in Psoriasis and Psoriatic Arthritis (GRAPPA) and International Consortium for Outcome Measures (ICHOM) for inflammatory arthritis. A/Prof Leung received the National Medical Research Council (NMRC) Transition Award in 2013. She has over 60 scientific publications.
Clinical Investigator and Senior Consultant,
Department of Rheumatology, Allergy and Immunology,
Tan Tock Seng Hospital
Dr Howe Hwee Siew is a clinical investigator and senior consultant with the Department of Rheumatology, Allergy and Immunology at Tan Tock Seng Hospital. She is also part of the clinical faculty at Yong Loo Lin School of Medicine.
A/Prof Anita Lim received her MB ChB degree from the University of Glasgow. Her rheumatology training was based in Addenbrooke's Hospital, Cambridge. The latter half of her training was at the Norfolk and Norwich University Hospital. She has been with NUH for over a decade, since 2005, in the Division of Rheumatology. She looks after the full spectrum of rheumatology patients.Her special interest is the transition of care from paediatric to adult rheumatology. She is also Vice-Chairman of the Medical Board, National University Hospital for Human Resource with a focus on ethics and quality improvement.